Your browser doesn't support javascript.
loading
Modified bi-weekly cetuximab-cisplatin and 5-FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients.
Meirovitz, Amichay; Bergerson, Shani; Hirshoren, Nir; Weinberger, Jeffrey M; Bersudski, Evgeniya; Daniel, Sharon; Sheva, Kim; Perez, Cesar A.
Afiliação
  • Meirovitz A; Department of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Bergerson S; Department of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hirshoren N; Department of Otolaryngology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Weinberger JM; Department of Otolaryngology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Bersudski E; Department of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Daniel S; Department of Pediatrics and Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Sheva K; Clalit Health Services, Southern Branch, Be'er Sheva, Israel.
  • Perez CA; Department of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Cancer Rep (Hoboken) ; 5(3): e1479, 2022 03.
Article em En | MEDLINE | ID: mdl-34184405

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article